20,62% | % de acciones controlado por personas con información privilegiada |
63,16% | % de acciones controlado por instituciones |
79,57% | % de capital flotante controlado por instituciones |
336 | Número de participaciones de instituciones |
Accionista | Acciones | Fecha de notificación | % fuera | Valor |
---|---|---|---|---|
QVT Financial LP | 112.541.536 | 30 dic 2023 | 13,97% | 1.279.597.251 |
SB Investment Advisers (UK) LTD | 73.031.667 | 30 dic 2023 | 9,06% | 830.370.045 |
Viking Global Investors, L.P. | 69.368.961 | 30 dic 2023 | 8,61% | 788.725.078 |
FMR, LLC | 36.976.248 | 30 dic 2023 | 4,59% | 420.419.935 |
Morgan Stanley | 21.927.044 | 30 dic 2023 | 2,72% | 249.310.487 |
Blackrock Inc. | 20.805.601 | 30 dic 2023 | 2,58% | 236.559.680 |
Rubric Capital Management LP | 19.000.000 | 30 dic 2023 | 2,36% | 216.029.997 |
State Street Corporation | 13.727.418 | 30 dic 2023 | 1,70% | 156.080.741 |
Wellington Management Group, LLP | 13.640.416 | 30 dic 2023 | 1,69% | 155.091.528 |
Patient Square Capital LP | 12.639.920 | 30 dic 2023 | 1,57% | 143.715.888 |
Accionista | Acciones | Fecha de notificación | % fuera | Valor |
---|---|---|---|---|
Fidelity Growth Company Fund | 10.865.857 | 30 mar 2024 | 1,35% | 123.544.792 |
iShares Core S&P Midcap ETF | 10.506.573 | 30 mar 2024 | 1,30% | 119.459.733 |
SPDR (R) Ser Tr-SPDR (R) S&P (R) Biotech ETF | 7.192.287 | 30 mar 2024 | 0,89% | 81.776.302 |
Vanguard Extended Market Index Fund | 4.945.664 | 30 dic 2023 | 0,61% | 56.232.199 |
Morgan Stanley Inst Fd Inc-Growth Port | 4.130.061 | 30 dic 2023 | 0,51% | 46.958.793 |
Fidelity Select Portfolios - Biotechnology | 3.856.619 | 30 mar 2024 | 0,48% | 43.849.757 |
iShares Biotechnology ETF | 3.612.345 | 30 mar 2024 | 0,45% | 41.072.362 |
Fidelity Growth Company K6 Fund | 3.528.158 | 30 mar 2024 | 0,44% | 40.115.156 |
Fidelity Series Growth Company Fund | 2.731.200 | 30 mar 2024 | 0,34% | 31.053.743 |
Fidelity Extended Market Index Fund | 1.863.938 | 28 feb 2024 | 0,23% | 21.192.974 |